Cargando…
Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials
BACKGROUND: Norepinephrine (NE) has currently been the first-choice vasopressor in treating septic shock despite generally insufficient for patients with refractory septic shock. The aim of this update meta-analysis was to assess the safety and efficacy of a combination of non-catecholamine vasopres...
Autores principales: | Zhong, Lei, Ji, Xiao-Wei, Wang, Hai-Li, Zhao, Guang-Ming, Zhou, Qing, Xie, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603734/ https://www.ncbi.nlm.nih.gov/pubmed/33292658 http://dx.doi.org/10.1186/s40560-020-00500-0 |
Ejemplares similares
-
Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis
por: Avni, Tomer, et al.
Publicado: (2015) -
Current use of vasopressors in septic shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2019) -
Vasopressors in Septic Shock: The Quest for Refinement
por: Pichamuthu, Kishore
Publicado: (2022) -
Vasopressors in septic shock: a systematic review and network meta-analysis
por: Zhou, Feihu, et al.
Publicado: (2015) -
Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)